Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

SEC Form: 1-A: Offering Statement [Regulation A]

https://www.sec.gov/Archives/edgar/data/1133818/000166357726000075/xsl1-A_X01/primary_doc.xml

SEC Form: 8-K – 5.03 – Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year – 8.01 – Other Events -9.01 – Financial Statements and Exhibits

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357726000064/bpth_8k031926.htm

SEC Form 1-Z: Exit Report

https://www.sec.gov/Archives/edgar/data/0001133818/000166357726000050/xsl1-Z_X01/primary_doc.xml

SEC Form-8K: Current Report 5.01 – Changes in Control of Registrant; 5.03 – Amendments to Articles of Incorporation; 7.01 – Regulation FD Disclosure; 8.01 – Other Events

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357726000046/bpth_8k022426.htm

Form 10-Q: Quarterly Report [Section 13 or 15(d)]


Quarterly report [Sections 13 or 15(d)] Open document

Form NT 10-Q: Notification of inability to timely file Form 10-Q or 10-QSB


Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K: Current report Open document Filing Open filing 5.02 – Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers 8.01 – Other Events

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357725000317/bpth_8k110425.htm

Form 8-K: Current Report Open Document Filing Open filing 5.02 – Departure of Directors or Certain Officers E

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000166357725000303/bpth_8k102225.htm

Form 10-Q: Quarterly Report [Sections 13 or 15(d)]

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001133818/000155837025011591/bpth-20250630x10q.htm

Form 8-K: Current report Open document Filing Open filing 4.01 – Changes in Registrant’s Certifying Accountant 9.01 – Financial Statements and Exhibits


Current report Open documentFilingOpen filing4.01 – Changes in Registrant’s Certifying Accountant9.01 – Financial Statements and Exhibits

Bio-Path Holdings

All Rights Reserved

Office:

625 Stanwix Street
Pittsburgh, PA, 15222

T: (630) 708-0750

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Scientifc Advisory Board
    • Directors
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us